- Home
- SBFM vs RBA Comparison
SBFM vs RBA Comparison
Compare SBFM & RBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- RBA
- Stock Information
- Founded
- SBFM 2006
- RBA 1958
- Country
- SBFM United States
- RBA United States
- Employees
- SBFM N/A
- RBA N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- RBA Business Services
- Sector
- SBFM Health Care
- RBA Consumer Discretionary
- Exchange
- SBFM Nasdaq
- RBA Nasdaq
- Market Cap
- SBFM 6.6M
- RBA 21.4B
- IPO Year
- SBFM N/A
- RBA 1998
- Fundamental
- Price
- SBFM $1.47
- RBA $118.04
- Analyst Decision
- SBFM Strong Buy
- RBA Buy
- Analyst Count
- SBFM 1
- RBA 5
- Target Price
- SBFM $15.00
- RBA $120.40
- AVG Volume (30 Days)
- SBFM 43.5K
- RBA 881.9K
- Earning Date
- SBFM 11-04-2025
- RBA 11-07-2025
- Dividend Yield
- SBFM N/A
- RBA 1.05%
- EPS Growth
- SBFM N/A
- RBA 14.00
- EPS
- SBFM N/A
- RBA 2.03
- Revenue
- SBFM $36,341,741.00
- RBA $4,418,000,000.00
- Revenue This Year
- SBFM $32.20
- RBA $6.23
- Revenue Next Year
- SBFM $32.74
- RBA $4.88
- P/E Ratio
- SBFM N/A
- RBA $58.13
- Revenue Growth
- SBFM 19.22
- RBA 4.66
- 52 Week Low
- SBFM $1.17
- RBA $78.08
- 52 Week High
- SBFM $3.90
- RBA $118.79
- Technical
- Relative Strength Index (RSI)
- SBFM 52.22
- RBA 61.34
- Support Level
- SBFM $1.45
- RBA $116.12
- Resistance Level
- SBFM $1.53
- RBA $118.91
- Average True Range (ATR)
- SBFM 0.06
- RBA 1.63
- MACD
- SBFM 0.01
- RBA 0.00
- Stochastic Oscillator
- SBFM 68.57
- RBA 85.07
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About RBA RB Global Inc.
RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.